Skip to main content
Jason Sicklick, MD, General Surgery, La Jolla, CA

JasonKeithSicklickMDFACS(He/Him)

General Surgery La Jolla, CA

Hepatobiliary Surgery, Surgical Oncology (Other than Breast)

Professor of Surgery, UC San Diego School of Medicine

Dr. Sicklick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sicklick's full profile

Already have an account?

  • Office

    3855 Health Sciences Dr
    La Jolla, CA 92093
    Phone+1 858-822-6173
    Fax+1 858-228-5153

Summary

  • Dr. Jason Sicklick is an NIH and FDA R01 funded investigator, Professor of Surgery, Executive Vice Chair of Research in the Department of Surgery, and Co-Leader of the Sarcoma Disease Team at the UC San Diego Moores Cancer Center. He is a board-certified general surgeon and surgical oncologist specializing in the treatment of complex retroperitoneal and abdominal sarcomas, including gastrointestinal stromal tumors (GIST), as well as hepatobiliary oncology. In 2016, Dr. Sicklick was named the GIST Clinician of the Year by the Life Raft GIST Support Group, the largest GIST patient advocacy group in the world. In 2018, Dr. Sicklick was selected as a James IV Association of Surgeons fellow. This highly prestigious international traveling fellowship is designed to promote communication and collaboration in the international surgical community. In 2018 he also received the RARE Champion of Hope in Medical Care & Treatment Award from the Global Genes-Allies in Rare Disease, the largest global non-profit advocacy organization for individuals and families fighting rare and genetic diseases. In 2019, he received the Excellence in Mentoring Award from the UC San Diego Health Systems International. In 2021, he received the Rare Impact Award from the National Organization for Rare Disorders (NORD®), which aims to provide support for individuals with rare diseases by advocating and funding research, education, and networking among service providers.

    He received his medical degree from the UCLA School of Medicine, completed his general surgery residency at The Johns Hopkins Hospital where he was the Administrative Chief Resident, and completed a fellowship in surgical oncology at Memorial Sloan Kettering Cancer Center where he was the Chief Administrative Fellow. He joined the UC San Diego Division of Surgical Oncology at Moores Cancer Center in 2010.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2008 - 2010
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Surgery, 2000 - 2008
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 2000

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2010 - 2026
  • NY State Medical License
    NY State Medical License 2008 - 2011
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • Top Doctors:San Diego Area Castle Connolly, 2013-2019
  • Fellow American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Advanced Basal Cell Cancer: Concise Review of Molecular Characteristics and Novel Targeted and Immune Therapeutics  
    J K Sicklick, P R Cohen, Annals of Oncology
  • Tumor Symbiosis: Gastrointestinal Stromal Tumor as a Host for Primary Peritoneal Mesothelioma  
    Sudeep Banerjee, Adam M Burgoyne, Joel Baumgartner, Amanda Kirane, Grace Y Lin, Jason Sicklick, Journal of gastrointestinal surgery
  • Role of Additional Organ Resection in Adrenocortical Carcinoma: Analysis of 167 Patients from the U.S. Adrenocortical Carcinoma Database  
    John Phay, Lawrence A Shirley, Lauren M Postlewait, Carmen C Solorzano, Colleen M Kiernan, Ioannis Hatzaras, Natalie Seiser, Tracy S Wang, Ryan C Fields, Konstantinos ..., Annals of Surgical Oncology
  • Join now to see all

Lectures

  • Investigation of profile-related evidence determining individualized cancer therapy (I-PREDICT) in heavily pre-treated patients: A role for combinatorial precision can... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Study Suggests Relationship Between Stromal Tumors and Mesothelioma
    Study Suggests Relationship Between Stromal Tumors and MesotheliomaAugust 2nd, 2022
  • Ripretinib Continues to Demonstrate Benefit in Advanced GIST
    Ripretinib Continues to Demonstrate Benefit in Advanced GISTNovember 11th, 2021
  • At Initial Cancer Diagnosis, a Deeply Personalised Assessment
    At Initial Cancer Diagnosis, a Deeply Personalised AssessmentOctober 14th, 2021
  • Join now to see all

Professional Memberships